CellBio  Vol.7 No.3 , September 2018
Quranic Verse No. 8 of Surat Al-Jumu’ah Leads us to Describe Cancer and Determine Its True Cause (Part-III)
Abstract: Therapeutic strategies for destroying cancer cells by making its death programs run again. The normal cell passes through several stages (Accumulation stage, Detoxification stage, Formation of free radical stage and Activation of nuclear factor kappa B stage and the shutting down of programs of cell death stage) to become a cancerous cell. The success of the therapeutic strategy to treat cancer depends on making either one or both programs of cell death run again. Shutting down one stage completely will be sufficient to stop the transformation of the natural cell into a cancerous cell, which eliminates the production of hydrogen peroxide, thus the activity of the NF-Kb will be inhibited. However, shutting down all stages is the most comprehensive therapeutic strategy and guarantees treatment success.
Cite this paper: El-Khodary, M. , (2018) Quranic Verse No. 8 of Surat Al-Jumu’ah Leads us to Describe Cancer and Determine Its True Cause (Part-III). CellBio, 7, 35-49. doi: 10.4236/cellbio.2018.73004.

[1]   Elkhodary, M.S.M. (2018) Quranic Verse No. 8 of Surat Al-Jumu’ah Describes Cancer as a Complete and Accurate Description and Leads Us to Determine the True Cause of Cancer. “Part-1”. CellBio, 7, 1-11

[2]   Jakoby, W.B. and Ziegler, D.M. (1990) The Enzymes of Detoxification. The Journal of Biological Chemistry, 256, 20715-20718.

[3]   Redlich, G., Zanger, U.M., Riedmaier, S., et al. (2008) Distinction between Human Cytochrome P450 (CYP) Isoforms and Identification of New Phosphorylation Sites by Mass Spectrometry. Journal of Proteome Research, 7, 4678-4688.

[4]   Yang, C.S., Smith, T.J. and Hong, J.-Y. (1994) Cytochrome P-450 Enzymes as Targets for Chemoprevention against Chemical Carcinogenesis and Toxicity: Opportunities and Limitations. Cancer Research, 54, 1982s-1986s.

[5]   Gonzalez, F.J. and Tukey, R.H. (2006) Drug Metabolism. In: Runtonll, B., Lazo, J.S. and Parker, K.L., Eds., Goodman and Gilman’s the Pharmacological Basis of Therapeutics, 11th Edition, McGraw Hill, New York, 71-91.

[6]   Hamdane, D., Zhang, H.M. and Hollenberg, P. (2008) Oxygen Activation by Cytochrome P450 Monooxygenase. Photosynthesis Research, 98, 657-666.

[7]   Kokogule, E., Belce, A., Ozyurt, E. and Tepeler, Z. (1990) Xanthine Oxidase Levels in Human Brain Tumors. Cancer Letters, 50, 179-181.

[8]   Sarnesto, A., Linder, K.O. and Raivio (1996) Organ Distribution and Molecular Forms of Human Xanthine Dehydrogenase/Xanthine Oxidase Protein. Laboratory Investigation, 74, 48-56.

[9]   Harrison, R. (2002) Structure and Function of Xanthine Oxido-Reductase: Where Are We Now? Free Radical Biology and Medicine, 33, 774-797.

[10]   Jelski, W., Zalewski, B. and Szmitkowski, M. (2008) Alcohol Dehydrogenase (ADH) Isoenzymes and Aldehyde Dehydrogenase (ALDH) Activity in the Sera of Patients with Liver Cancer. Journal of Clinical Laboratory Analysis, 22, 204-209.

[11]   Kiefer, D. (2005) Report a Little-Known Fact: Alcohol Is a Carcinogen. Life Extension Magazine, 2-3.

[12]   Shaw, S. and Elithabeth, J. (1990) The Role of Aldehyde Oxidase in Ethanol-Induced Hepatic Lipid Peroxidation in the Rat. Biochemical Journal, 265, 579-583.

[13]   Toninello, A., Pietrangeli, P., Demarchiu, Salvi, M. and Mondovi, B. (2006) Amino-Oxidase in Apoptosis and Cancer. Biochimica et Biophysica Acta, 1765, 1-13.

[14]   Shin, J.C. and Chenk (2004) Regulation of MAO-A and MAO-B Gene Expression. Current Medicinal Chemistry, 11, 1995-2005.

[15]   Richardson, J.S. (1993) On the Functions of Monoamine Oxidase, the Emotions, and Adaptation to Stress. International Journal of Neuroscience, 70, 75-84.

[16]   Wallace, H.M., Duthie, J., Evans, D.M., Lamond, S., Nicoll, K.M. and Heys, S.D. (2000) Alteration in Polyamine Catabolic Enzymes in Human Breast Cancer Tissue. Clinical Cancer Research, 6, 3657-3661.

[17]   Motohashi, H. and Yamamoto, M. (2004) Nrf2-keap1 Defines a Physiologically Important Stress Response Mechanism. Trends in Molecular Medicine, 10, 549-557.

[18]   Jung, K.A. and Kwak, M.K. (2010) The Nrf2 System as a Potential Target for the Development of Indirect Antioxidants. Molecules, 15, 7266-7291.

[19]   Sheehan, D., Meada, G., Foley, V.M. and Dowd, C.A. (2001) Structure, Function and Evolution of Glutathione Transferases: Impactions for Classification of Non-Mammalian Members of an Ancient Enzyme Superfamily. Biochemical Journal, 360, 1-16.

[20]   Jancova, P., Anzenbacher, P. and Anzenbacherova, E. (2010) Phase-II Drug Metabolizing Enzymes. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 154, 103-116.

[21]   Habuchi, O. (2000) Diversity and Functions of Glycosaminoglycan Sulfotransferases. Biochimica et Biophysica Acta, 1474, 115-127.

[22]   Mulder, G.J. (1990) Conjugation Reactions in Drugs Metabolism: An Integrated Approach: Substrates. Co-Substrates. Enzymes and Their Interactions in Vivo and in Vitro. Taylor and Francis, Abingdon-on-Thames, 413 p.

[23]   Hodgson (2010) A Textbook of Modern Toxicology. 67.

[24]   Keppler, D. (2011) Multidrug Resistance Proteins (MRPs, ABCCs): Importance for Pathophysiology and Drug Therapy. Handbook of Experimental Pharmacology, 201, 299-323.

[25]   Mizuno, N., Yotsumoto, T. and Sugiyama, Y. (2003) Impact of Drug Transporter Studies on Drug Discovery and Development. Pharmacological Reviews, 55, 425-461.

[26]   Kensler, T.W., Qian, G.-S., Chen, J.-G. and Groopman, J.D. (2003) Translational Strategies for Cancer Prevention in Liver. Nature Review Cancer, 3, 321-329.

[27]   Sporn, M.B. and Liby, K. (2012) NRF2 and Cancer: The Bad and the Importance of Context. Nature Reviews Cancer, 12, 564-571.

[28]   Hayes, J.D., McMahon, M., Chowdhry, S. and Dinkova-Kostova, A.T. (2010) Cancer Chemoprevention Mediated through the keap1-Nrf2 Pathway. Antioxidants & Redox Signaling, 13, 1713-1748.

[29]   Talalay, P. (2000) Chemo Protection against Cancer by Induction of Phase 2 Enzymes. BioFactors, 12, 5-11.

[30]   Lui, T., Stern, A. and Robert, L.J. (1999) The Isoprostanes: Novel Prostaglandin-Like Products of the Free Radical Catalyzed Peroxidation of Arachidonic Acid. Journal of Biomedical Science, 6, 226-235.

[31]   Biaglow, J.E., Mitcgell, J.B. and Held, K. (1992) The Importance of Peroxide and Superoxide in x-Ray Response. International Journal of Radiation Oncology, Biology, Physics, 22, 665-669.

[32]   Sayre, L.M., Smith, M.A. and Perry, G. (2001) Chemistry and Biochemistry of Oxidative Stress in Neurodegenerative Disease. Current Medicinal Chemistry, 8, 721-738.

[33]   Diplock, A.T., Charleux, J.L., Crozier-Willi, G., et al. (1998) Functional Food Science and Defense against Reactive Oxygen Species. British Journal of Nutrition, 80, S77-S112.

[34]   Valko, M., Leibfrits, D., Moncol, J., et al. (2007) Free Radicals and Antioxidants in Normal Physiological Functions and Human Disease. International Journal of Biochemistry &Cell Biology, 39, 44-84.

[35]   Karthikeyan, R., Manivasagam, T., Anantharaman, P., Balasubramanian, T. and Somasundaram, S.T. (2010) Chemopreventive Effect of Padina boergesenii Extracts on Ferric Nitrilotricetate (Fe-NTA)-Induced Oxidative Damage in Wister Rats. Journal of Applied Phycology, 23, 257-263.

[36]   Han, S., Li, Y.Y. and Chan, B.P. (2015) Protease Inhibitors Enhance Extracellular Collagen Fibril Deposition in Human Mesenchymal Stem Cells. Stem Cell Research & Therapy, 6, 197.

[37]   Donato, L.J. and Noy, N. (2005) Supression of Mammary Carcinoma Growth by Retinoic Acid: Proapoptotic Genes Are Targets for Retinoic Acid Receptor and Cellular Retinoic Acid Binding Protein II Signaling. Cancer Research, 65, 8193-8199.

[38]   Birben, E., Sahiner, U.M., Sackesen, C., Erzurum, S. and Kalayci, O. (2012) Oxidative Stress and Antioxidant Defence. World Allergy Organization Journal, 5, 9-19.

[39]   Soonlae, R., Chul, J.Y. and Hwa, C.J. (2005) Effects of Vitamin E on Phospholipase A2 Activity and Oxidative Damage to the Liver in Streptozotocin-Induced Diabetic Rats. Annals of Nutrition and Metabolism, 49, 392-396.

[40]   Sheng, Y., Abreu, I.A., Cabelli, D.E., Maroney, M.J., Miller, A., Teixeiera, M. and Valentine, J.S. (2014) Superoxide Dismutases and Superoxide Reductases. Chemical Reviews, 114, 3854-3918.

[41]   Irshad, M. and Chaudhuri, P.S. (2002) Oxidant-Antioxidant System: Role and Significance in Human Body. Indian Journal of Experimental Biology, 40, 1233-1239.

[42]   Schreck, R., Rieber, P. and Baeuerle, P.A. (1991) Reactive Oxygen Intermediates as Apparently Widely Used Messengers in the Activation of the NF-kappa B Transcription Factor and HIV-1. The EMBO Journal, 10, 2247-2258.

[43]   Kim, H., Seo, J.Y., Roh, K.H., Lim, J.W. and Kim, K.H. (2000) Suppression of NF-kappa B Activation and Cytokine Production by N-acetylcysteiene in Pancreatic Acinar Cells. Free Radical Biology & Medicine, 29, 674-683.

[44]   Ye, J., Ding, M., Zhang, X., Rojanasakul, Y. and Shi, X. (2000) On the Role of Hydroxyl Radical and the Effect of Tetrandrine on Nuclear Factor-Kappa B Activation by Phorbol 12-Myristate 13-Acetate. Annals of Clinical & Laboratory Sciences, 30, 2000.

[45]   Jung, Y., Kim, H., Min, S.H., Rhee, S.G. and Jeong, W. (2008) Dynein Light Chain LC8 Negatively Regulates NF-kb through the Redox-Dependent Interaction with IKB-α. The Journal of Biological Chemistry, 283, 23863-23871.

[46]   Yamamoto, Y. and Gaynor, R.B. (2001) Therapeutic Potential of Inhibition of NF-Kb Pathway in the Treatment of Inflammation and Cancer. The Journal of Clinical Investigation, 107, 135-142.

[47]   Elkhodary, M. (2018) Quranic Verse No. 8 of Surat Al-Jumu’ah Leads Us to Describe Cancer and Determine Its True Cause. Part-II.

[48]   Dinkova-Kostova, A.T., Holtzclaw, W.D., Cole, R.N., et al. (2002) Direct Evidence That Sulfhydryl Groups of Keap1 Are the Sensors Regulating Induction of Phase 2 Enzymes That Protect against Carcinogens and Oxidants. Proceedings of the National Academy of Sciences, 99, 11908-11913.

[49]   Kagan, V.E., Kisin, E.R., Kawai, K., et al. (2002) Towards Mechanism = Base Antioxidant Interventions. Annals of the New York Academy of Sciences, 959, 188-198.

[50]   Packer, L. and Ong, A.S.H. (1998) Biological Oxidants and Antioxidants: Molecular Mechanisms and Health Effects. AOCS Press, Champaign.

[51]   Yin, M.J., Yamamoto, Y. and Gaynor, R.B. (1998) The Anti-Inflammatory Agent Aspirin and Salicylate Inhibitor the Activity of IkB Kinase-β. Nature, 396, 77-80.

[52]   Fuhr, U. and Klittich Staib, A.H. (1993) Inhibitory Effect of Grapefruit Juice and Its Bitter Principle, Naringenin, on CYP1A2 Dependent Metabolism of Caffeine in Man. The Journal of Clinical Pharmacology, 35, 431-436.

[53]   Lin, S., Zhang, G., Liao, Y., Pan, J. and Gong, D. (2015) Dietary Flavonoids as Xanthine Inhibitors: Structure Affinity and Structure-Activity Relationships. Journal of Agricultural and Food Chemistry, 63, 7784-7794.

[54]   Veeriah, S., Miene, C., Habermann, N., et al. (2008) Apple Polyphenols Modulate Expression of Selected Genes Related to Toxicological Defence and Stress Response in Human Colon Adenoma Cells. International Journal of Cancer, 122, 2647-2655.

[55]   Sze, W.T., San, C.W., Han, L.C., Man, L.W., Yan, T.W., Wah, T.S., Yin, T.K., Kuen, H.W. and Wai, C.Y. (2010) Curcumin Alters the Migratory Phenotype of Nasopharyngeal Carcinoma Cells through Up-Regulation of E-Cadherin. International Institute of Anticancer Research, 30, 2851-2856.

[56]   Goldstein, I., Marcel, V., Olivier, M., Oren, M., Rotter, V. and Hainaut, P. (2011) Understanding Wild-Type and Mutant P53 Activities in Human Cancer: New Landmarks on the Way to Targeted Therapies. Cancer Gene Therapy, 18, 2-11.